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Abstract
Introduction: Observational studies provide evidence for an association between potassium intake and BP levels. However, uncertain-
ties still exist about the size and the shape of this relation. Conversely, experimental studies have not been used to estimate
dose-response curves, since standard methods can only be applied in trials including at least three exposure groups.
Materials and Methods: We carried out a systematic review of the evidence concerning the effect of potassium supplementation on
blood pressure in epidemiologic experimental studies. Following a PubMed search up to June 20, 2019, we included randomized con-
trolled trials (RCTs) encompassing potassium supplementation as the only intervention for at least four weeks. We used a restricted
cubic spline model and the ‘one-stage’ approach to perform a dose-response meta-analysis, a newly-developed statistical procedure
which allows inclusion of studies with as few as two categories of exposure (Stat Methods Med Res. 2019;28:1579–1596). Finally,
we repeated the analyses stratifying for hypertensive status and use of anti-hypertensive medication.
Results: Overall, we included 33 studies carried out in adult population, with potassium supplementation ranging from 30 to 140
mmol/day. RCTs’ duration ranged from 4 up to 26 weeks. Most of the studies have a cross-over design (N = 24), include hypertensive
individuals (N = 27) and subjects not under anti-hypertensive medication (N = 27). Overall, an increase of 40, 80 and 120mmol/day of
potassium resulted in reductions of SBP by -5.64 (95% CI - 8.78, -2.50), -4.62 (-6.41, -2.84) and -2.54 mmHg (95% CI -5.14, + 0.06),
respectively. Higher potassium intakes also resulted in reduced DBP levels by -3.57 (95% CI -5.55, -1.59), -3.07 (95% CI -5.07, -1.08),
and -1.92 mmHg (95% CI -5.65, 1.81). The effect of increasing potassium intake on BP was larger among hypertensives than normo-
tensives, and among pharmacologically untreated hypertensives compared to their treated counterparts. Subgroup analyses according
to study design (parallel vs. crossover) yielded similar results.
Discussion: With the application of advanced dose-response modeling on RCT results, we found a U-shaped relation between potas-
sium intake and blood pressure. A low to moderate increase in potassium intake resulted in a progressive reduction in blood pressure,
which was reversed at higher levels of potassium supplementation. The effect was stronger among untreated hypertensives.
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